Next Article in Journal
Systematic Review on Upper Urinary Tract Carcinoma in Kidney Transplant Recipients
Previous Article in Journal
The Core of the Issue: Plank Performance and Pain in the Lower Back
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Molecular Identification of Blastocystis Subtypes in the Cervix: A Study on Polish Patients

by
Barbara Suchońska
1,†,
Adam Kaczmarek
2,3,†,
Maria Wesołowska
4,
Daniel Młocicki
5 and
Rusłan Sałamatin
2,5,*
1
1st Department of Obstetrics and Gynaecology, Medical University of Warsaw, 02-015 Warsaw, Poland
2
Department of Microbiology and Parasitology, Faculty of Medical Science. Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, 01-938 Warsaw, Poland
3
Department of Parasitology and Vector-Borne Diseases, National Institute of Public Health NIH—National Research Institute, 00-791 Warsaw, Poland
4
Department of Biology and Medical Parasitology, Wrocław Medical University, 50-345 Wrocław, Poland
5
Department of General Biology and Parasitology, Medical University of Warsaw, 02-004 Warsaw, Poland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2025, 14(11), 3928; https://doi.org/10.3390/jcm14113928
Submission received: 7 May 2025 / Revised: 29 May 2025 / Accepted: 31 May 2025 / Published: 3 June 2025
(This article belongs to the Section Infectious Diseases)

Abstract

Background: Blastocystis is a common protozoan often found in the gastrointestinal tract of humans. The presence of Blastocystis in the female genital tract—has been reported three times, but the genetic material of the protozoan from this site has been identified only once. Methods: Patients with cervical erosions were enrolled in the study. Samples were collected using dry swabs. Blastocystis DNA was detected using real-time PCR and sequenced. Results: Thirty patients with cervical erosions were examined. The presence of Blastocystis genetic material was confirmed in nine female patients. Blastocystis subtypes ST1, ST6, and ST7 were recovered from the ectocervix and distal part of the cervical canal of women with large, symptomatic glandular ectopies resistant to standard treatment. In one case, we identified a Blastocystis subtype ST7 in the material from the cervix, which was different from subtype ST3 found in the anus of the same woman. Conclusions: This observation indicates a possible role for Blastocystis in cervical erosions and suggests that eradication of these organisms may relieve this condition.

1. Introduction

Blastocystis are anaerobic protozoans that commonly occur in the human digestive tract [1,2,3,4]. They are characterized by considerable morphological and genetic polymorphisms—with 44 distinct subtypes described to date [5,6,7,8]. In general, the occurrence of Blastocystis in humans is estimated to be 10% of the population in developed countries to 100% in developing countries, which is related to the level of hygiene [1,2,3,4,9,10,11].
They are among the group of protozoans that are most commonly detected in fecal samples, but there is considerable controversy regarding their pathogenicity [2,3,12,13,14,15]. There is no consensus on the role of Blastocystis in digestive tract diseases [16]. However, some studies suggest that Blastocystis may alter the gut microbiome and thus influence processes involved in intestinal inflammation in a protective manner [17]. It is also suggested that outside the digestive tract, the protozoan may become a parasite [18,19].
Currently, it is known that Blastocystis does not occur in the vagina or cervix under physiological conditions. Only one report described the presence of Blastocystis in vaginal swabs from patients with ‘erosions’ [18].
Recently, two papers have confirmed the presence of Blastocystis in the cervix and vagina based on microscopic examination and genetic analysis [19,20]. Villalobos et al. described the presence of Blastocystis in the vagina of women and in the semen of men infected with Trichomonas vaginalis [20]. This paper sheds new light on the mode of Blastocystis transmission. In this paper, we report a rare case of Blastocystis detected at an atypical site within the human body—the cervix. To explore the potential source of this unusual infection, we also investigated the presence of Blastocystis in the anal region of the affected women.

2. Materials and Methods

2.1. Study Group and Control Group

The research was performed on patients reporting to the cervical Counselling section of the Outpatient Clinic at the First Department of Obstetrics and Gynecology; they were recruited for the research during routine visits to the clinic. Women who were not menstruating and had not engaged in sexual intercourse within the last 24 h at the time of sample collection were selected.
The study group included 30 regularly menstruating patients of reproductive age (18–50 years old), who had cervical erosion for at least one year, that is, extensive glandular ectopy on the ectocervix, for which attempts at pharmacological treatment had been made. The patients qualified for this group were not pregnant, did not suffer from DM (diabetes mellitus), were not being treated with immunosuppressants, were not taking steroids (which lowers the immune response), and had not used local or systemic metronidazole or cotrimoxazole for the last three months. The control group comprised 30 healthy women of reproductive age without any macroscopic lesions of the cervix, without reported chronic diseases, and without erosion. All patients provided informed consent to participate in the study. A current, normal Pap smear result was also a condition for inclusion in the study. Patient data were anonymized for this study.
The samples were transferred to an employee of the Chair of Biology and Parasitology of the Medical University of Warsaw, and the analysis was performed in the Department of Parasitology and Vector Borne Diseases of the National Institute of Hygiene (Current official name (in English): National Institute of Public Health NIH—National Research Institute), where the material was stored, analyzed, and utilized.
Cervical and anal swabs were collected from patients in the study group. Only cervical swabs were collected from patients in the control group.

2.2. Sample Collection

In the study group, samples were collected using two separate dry swabs: one from the ectocervix and the area of the external os of the cervical canal, and the second from the anus at a minimum depth of 1 cm, collecting a minimal amount of fecal material. For the control group, sampling was limited to cervical swabs. We used sterile kits composed of a tube containing a transport medium with added charcoal and a rod with a viscose head and a cork at the opposite end (Deltalab (Rubí Barcelona, Spain), Cat. No. 300285) [21,22]. The test tubes containing the material were transferred to the microbiology laboratory shortly after collection. The samples were stored in a refrigerator at 4 °C until DNA isolation, which was performed on the same or the following day.

2.3. Molecular Identification and Sequencing

DNA was isolated from the samples using Genomic Mini kits (A&A Biotechnology, Gdynia, Poland). A fragment of the small subunit ribosomal RNA (rRNA) was amplified using the Bl18SPPF1 and BL18SR2PP primers and/or the RD5 and BHRDr primers (Table 1, Figure 1).
qPCR amplification was carried out using the Rotor-Gene 6000 system (Corbett Life Science, Paris, France). For each PCR reaction, 2 μL of DNA solution was added, and the total volume of all PCR samples was adjusted to 20 μL. This included 1× concentrated SsoFast™ EvaGreen Supermix and 500 nM of primers. After an initial denaturation step at 95 °C for 5 min, 45 cycles were conducted, with denaturation at 95 °C for 5 s, annealing at 68 °C for 10 s, and extension at 72 °C for 15 s. Signal detection occurred in the green channel at the end of incubation at 72 °C during every cycle.
The resulting products were visualized by electrophoresis on a 2% agarose gel, and the excised bands were purified using a Gel-Out kit (A&A Biotechnology, Gdańsk, Poland). Sequencing was conducted using the Sanger method at the Institute of Biochemistry and Biophysics, Warsaw, Polish Academy of Sciences. Chromatograms were analyzed using CLC Main Workbench v 21.0.6 software (QIAGEN Aarhus A/S, Aarhus, Denmark). The obtained sequences, excluding the primer regions, were compared with those available in the GenBank database using the BLAST tool v. 2.15.0 [26]. Phylogenetic analysis was performed using Bayesian inference [27,28,29], incorporating 104 reference sequences representing Blastocystis ST1–ST44 subtypes [7,21,30,31,32] (Table 2). Proteromonas lacertae (GenBank: U37108) was used as the outgroup.
The sequences have been deposited in GenBank (accession numbers PQ459511–PQ459520). Blastocystis subtype nomenclature is according to Stensvold et al. [33].
This study was approved by the Bioethical Committee of the Medical University of Warsaw (consent number KB1/175/2019; 30 October 2019). All patients provided their written informed consent.

3. Results

3.1. The Group of Patients with Cervical Erosion

In the group with cervical erosion, Blastocystis DNA was detected in both cervical and anal swabs, with varying subtype (STs) distributions.
Phylogenetic analysis (Figure 1) showed that the examined samples corresponded to Blastocystis subtypes ST1, ST3, ST6, and ST7. Table 3 provides a detailed overview of Blastocystis detection in individual patients. Blastocystis was detected in cervical swabs of six patients, while four patients tested positive for the parasite in anal swabs. The specific distribution of the subtypes (STs) is presented in Table 3. Blastocystis was present in the swabs of patients 7, 9, 17, 19, 22, and 30. The identified subtypes included ST1, ST6, and ST7.
Anal swabs resulted in four patients [4,6,7,19] testing positive, with identified subtypes ST1, ST3, and ST7. Interestingly, Patient 7 tested positive for Blastocystis in both cervical and anal swabs, with different subtypes (ST7 in the cervix and ST3 in the anus).

3.2. Control Group

No Blastocystis DNA was detected in either the cervical or anal swabs of the control group. This suggests a potential association between cervical erosion and Blastocystis colonization or infection in women.

4. Discussion

Until recently, only a few authors have confirmed the presence of Blastocystis in cervical smears from patients with cervical inflammation. Our molecular findings suggest that Blastocystis may colonize the cervical region in certain cases, potentially influenced by erosion, and demonstrate subtype diversity across different anatomical sites.
For a long time, the presence of Blastocystis was detected only microscopically [18,34,35,36]. This method was also employed by Escutia-Guzman et al. to confirm the presence of HPV in the cervix [19]. Wołyńska and Soroczan [18] hypothesized that these protozoa could be the etiological factor for non-healing erosions, which have been a therapeutic problem. The presence of this microorganism in 11.5% (47/312) of the analyzed population was accompanied by colpitis in 51% (24/47) and cervical erosion in 32% (15/47). No pathology was found in the genital tract in 17% (8/47) of the cases. Until recently, this was the only paper addressing the parenteral localization of Blastocystis and remains the sole study involving such a large group of subjects (319 women), based on which the authors attempted to draw clinical conclusions. PCR analysis allows for an unequivocal diagnosis that is independent of the subjective opinion of the researcher [37,38,39,40,41].
In 2020, a case of extraintestinal Blastocystis was published involving a patient with relatively mild symptoms of cervical inflammation [19]. A cytological swab was taken, and the presence of Blastocystis sp. was noted microscopically. This was confirmed by PCR analysis of material taken from the anus; however, PCR was not performed on the cervical material. It should not be assumed that the Blastocystis present in the anus is identical to that in the genital tract. The presence of Blastocystis infection is not routinely assessed in cytological smears, and no appropriate standards have been implemented. The authors suggested that the inability to prove the presence of the protozoan in the cervix was likely due to the topical use of over-the-counter drugs. This may indicate the effectiveness of metronidazole in eradicating the infection, but it could also suggest that the patient’s cervix was not colonized. A clinical case of the parenteral occurrence of Blastocystis has been described without any definitive confirmation of this hypothesis. Based on our research, we believe that Blastocystis can be present in the cervix, and we have incontestable evidence of this fact. Some of our patients had infections solely in the cervix, while others had infections exclusively in the anus or both locations. It seems that the presence of Blastocystis in the anus does not, with any certainty, indicate its presence in the vagina and the cervix. Even if the protozoan is present in both locations, it does not have to be the same subtype. We confirmed the presence of subtypes ST1, ST6, and ST7 in the cervix, whereas subtypes ST1, ST3, and ST7 were present in the anus. In the patient in whom the protozoan was present in both the vagina and the anus, it was determined with absolute certainty that these were two different subtypes: ST7 in the vagina and ST3 in the anus. The confirmation of the presence of Blastocystis in the cervix with a simultaneous absence of typical or pronounced clinical symptoms, as observed in our patients, suggests the extraordinary ability of these microorganisms to occupy new niches and adapt to new conditions. Unfortunately, confirming their presence does not equate to identifying the etiological agent for all cervical erosions. It is unclear how to effectively eliminate this infection in patients with such atypical parasite locations.
Bacterial, viral, and fungal infections are common in the vagina and the distal half of the cervix. However, protozoan infections are much less frequent in this area, with T. vaginalis being the most common [19,20]. Therefore, colonization of the cervix by Blastocystis in a patient with exceptionally mild symptoms (limited to itching) is particularly atypical.
The authors of the most recent paper were able to perform molecular identification of Blastocystis subtypes ST1–ST3 in samples taken from the reproductive organs of six women (21.4% of patients tested) and three men (42.8%) infected with T. vaginalis, the protozoan responsible for most non-viral sexually transmitted infections. According to the authors, this confirms the great ability of these protozoa to colonize all available niches [19,20].
Similar to the results of our study, Wołyńska, and Soroczan suggested that Blastocystis may be present in both the vagina and the anus, but not necessarily simultaneously in the same patient [18]. All women with confirmed infection exhibited symptoms of inflammation or cervical erosion. However, doubts have been raised regarding how Blastocystis reaches the cervix and colonizes this area. This may be correlated with an active sex life and/or poor hygiene. The mechanism of autonomous microorganism transfer, or transfer induced by everyday hygiene activities performed by the women themselves through transfer due to the close proximity of the anus and vagina, has been recognized for years in the oral supplementation of gynecological probiotics [42,43,44]. A similar mechanism, though not considered beneficial, could play a role in the transfer of Blastocystis and colonization of female genital organs.
Considering that the presence of Blastocystis has been confirmed in semen, the possibility of sexual transmission cannot be excluded, especially through vaginal intercourse, with no connection to neglecting hygiene.
In summary, Blastocystis can occur not only in the alimentary tract and anus but also in other locations in the anogenital area. In our study, Blastocystis was found in the cervixes of six out of thirty (20%) patients who had extensive non-healing erosions and in none of the control groups who had no erosions. Based on the literature data, we expected to find Blastocystis in cervixes affected by erosions. Therefore, using genetic analysis and sequencing, we confirmed the results of Wołyńska and Soroczan.
Similar to other researchers studying Blastocystis, we could not conclusively determine whether these protozoans are commensals or parasites at this cervical location. To date, research has not been conducted on a sufficiently large patient group to assess the extent of this phenomenon and the true frequency of Blastocystis co-occurrence with cervical lesions. In our pilot study, which involved a relatively small sample of patients, we sought to determine whether Blastocystis colonization of the cervix could be confirmed using molecular methods and whether it occurred more frequently in women with erosions. We found positive answers to both questions. However, the issue of whether treatment is necessary, and if so, how it should be approached, remains unresolved and requires further investigation.

Author Contributions

Conceptualization, B.S., A.K., M.W., D.M. and R.S.; methodology, B.S., A.K. and R.S.; formal analysis, M.W. and D.M.; investigation, B.S., A.K. and R.S.; resources, B.S., D.M. and R.S.; data curation, R.S.; writing—original draft preparation, B.S. and R.S.; writing—review and editing, B.S., A.K., M.W., D.M. and R.S.; visualization, R.S.; supervision, R.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Bioethical Committee of the Medical University of Warsaw (consent number KB1/175/2019; 30 October 2019).

Informed Consent Statement

Informed consent was obtained from all the participants involved in the study.

Data Availability Statement

The dataset from this study is held securely in coded form at the Medical University of Warsaw. Data-sharing agreements prohibit making the dataset publicly available. However, the data can be made available upon reasonable request to the corresponding author (RS) after obtaining the necessary ethical and data sharing approvals.

Acknowledgments

We extend our gratitude to Laurence Taylor, Warsaw, for meticulously reviewing the article and guaranteeing its precision and lucidity.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. El Safadi, D.; Gaayeb, L.; Meloni, D.; Cian, A.; Poirier, P.; Wawrzyniak, I.; Delbac, F.; Dabboussi, F.; Delhaes, L.; Seck, M.; et al. Children of Senegal River Basin Show the Highest Prevalence of Blastocystis sp. Ever Observed Worldwide. BMC Infect. Dis. 2014, 14, 164. [Google Scholar] [CrossRef] [PubMed]
  2. Turkeltaub, J.A.; McCarty, T.R.; Hotez, P.J. The Intestinal Protozoa: Emerging Impact on Global Health and Development. Curr. Opin. Gastroenterol. 2015, 31, 38–44. [Google Scholar] [CrossRef] [PubMed]
  3. Scanlan, P.D. Blastocystis: Past Pitfalls and Future Perspectives. Trends Parasitol. 2012, 28, 327–334. [Google Scholar] [CrossRef] [PubMed]
  4. Zierdt, C.H. Blastocystis hominis—Past and Future. Clin. Microbiol. Rev. 1991, 4, 61–79. [Google Scholar] [CrossRef]
  5. Tan, K.S.W.W. New Insights on Classification, Identification, and Clinical Relevance of Blastocystis spp. Clin. Microbiol. Rev. 2008, 21, 639–665. [Google Scholar] [CrossRef]
  6. Villalobos, G.; Orozco-Mosqueda, G.E.; Lopez-Perez, M.; Lopez-Escamilla, E.; Córdoba-Aguilar, A.; Rangel-Gamboa, L.; Olivo-Diaz, A.; Romero-Valdovinos, M.; Maravilla, P.; Martinez-Hernandez, F. Suitability of Internal Transcribed Spacers (ITS) as Markers for the Population Genetic Structure of Blastocystis spp. Parasit. Vectors 2014, 7, 461. [Google Scholar] [CrossRef]
  7. Santin, M.; Figueiredo, A.; Molokin, A.; George, N.S.; Köster, P.C.; Dashti, A.; González-Barrio, D.; Carmena, D.; Maloney, J.G. Division of Blastocystis ST10 into Three New Subtypes: ST42-ST44. J. Eukaryot. Microbiol. 2024, 71, e12998. [Google Scholar] [CrossRef]
  8. Koehler, A.V.; Herath, H.M.P.D.; Hall, R.S.; Wilcox, S.; Gasser, R.B. Marked Genetic Diversity within Blastocystis in Australian Wildlife Revealed Using a next Generation Sequencing–Phylogenetic Approach. Int. J. Parasitol. Parasites Wildl. 2024, 23, 100902. [Google Scholar] [CrossRef]
  9. Ramírez, J.D.; Sánchez, A.; Hernández, C.; Flórez, C.; Bernal, M.C.; Giraldo, J.C.; Reyes, P.; López, M.C.; García, L.; Cooper, P.J.; et al. Geographic Distribution of Human Blastocystis Subtypes in South America. Infect. Genet. Evol. 2016, 41, 32–35. [Google Scholar] [CrossRef]
  10. Villegas-Gómez, I.; Martínez-Hernández, F.; Urrea-Quezada, A.; González-Díaz, M.; Durazo, M.; Hernández, J.; Orozco-Mosqueda, G.E.; Villalobos, G.; Maravilla, P.; Valenzuela, O. Comparison of the Genetic Variability of Blastocystis Subtypes between Human Carriers from Two Contrasting Climatic Regions of México. Infect. Genet. Evol. 2016, 44, 334–340. [Google Scholar] [CrossRef]
  11. Šejnohová, A.; Koutenská, M.; Jirků, M.; Brožová, K.; Pavlíčková, Z.; Kadlecová, O.; Cinek, O.; Maloney, J.G.; Santín, M.; Petrželková, K.J.; et al. A Cross-Sectional Survey of Blastocystis sp. and Dientamoeba fragilis in Non-Human Primates and Their Caregivers in Czech Zoos. One Health 2024, 19, 100862. [Google Scholar] [CrossRef] [PubMed]
  12. Yakoob, J.; Jafri, W.; Beg, M.A.; Abbas, Z.; Naz, S.; Islam, M.; Khan, R. Irritable Bowel Syndrome: Is It Associated with Genotypes of Blastocystis hominis. Parasitol. Res. 2010, 106, 1033–1038. [Google Scholar] [CrossRef]
  13. Jimenez-Gonzalez, D.E.; Martinez-Flores, W.A.; Reyes-Gordillo, J.; Ramirez-Miranda, M.E.; Arroyo-Escalante, S.; Romero-Valdovinos, M.; Stark, D.; Souza-Saldivar, V.; Martinez-Hernandez, F.; Flisser, A.; et al. Blastocystis Infection Is Associated with Irritable Bowel Syndrome in a Mexican Patient Population. Parasitol. Res. 2012, 110, 1269–1275. [Google Scholar] [CrossRef]
  14. Al-Tawil, Y.S. Invasive Blastocystis hominis Infection in a Child. Arch. Pediatr. Adolesc. Med. 1994, 148, 882–885. [Google Scholar] [CrossRef] [PubMed]
  15. Janarthanan, S.; Khoury, N.; Antaki, F. An Unusual Case of Invasive Blastocystis hominis Infection. Endoscopy 2011, 43, E185–E186. [Google Scholar] [CrossRef] [PubMed]
  16. Leder, K.; Hellard, M.E.; Sinclair, M.I.; Fairley, C.K.; Wolfe, R. No Correlation between Clinical Symptoms and Blastocystis hominis in Immunocompetent Individuals. J. Gastroenterol. Hepatol. 2005, 20, 1390–1394. [Google Scholar] [CrossRef]
  17. Billy, V.; Lhotská, Z.; Jirků, M.; Kadlecová, O.; Frgelecová, L.; Parfrey, L.W.; Pomajbíková, K.J. Blastocystis Colonization Alters the Gut Microbiome and, in Some Cases, Promotes Faster Recovery From Induced Colitis. Front. Microbiol. 2021, 12, 641483. [Google Scholar] [CrossRef]
  18. Wołyńska, M.; Soroczan, W. [Blastocystis hominis Brumpt, 1912, (Phycomycetes) in the Female Genital Tract]. Pol. Tyg. Lek. 1972, 27, 788–791. [Google Scholar]
  19. Escutia-Guzman, Y.; Martinez-Flores, W.A.; Martinez-Ocaña, J.; Martinez-Pimentel, R.; Benitez-Ramirez, M.; Martinez-Hernandez, F.; Arroyo-Escalante, S.; Romero-Valdovinos, M.; Orozco-Mosqueda, G.E.; Maravilla, P. An Unusual Case of Extra-Enteric Blastocystosis in the Uterine Cervix. Korean J. Parasitol. 2020, 58, 571–576. [Google Scholar] [CrossRef]
  20. Villalobos, G.; Sanchez-Aguillon, F.; Carmona-Maldonado, M.V.; Gonzalez-Arenas, N.R.; Lopez-Escamilla, E.; Hernandez-Castro, R.; Romero-Valdovinos, M.; Martinez-Flores, W.A.; Ramirez-Hinojosa, J.P.; Maravilla, P.; et al. Unexpected Presence of Blastocystis Subtype 1–3 DNA in Human Vaginal and Sperm Samples Coinfected with Trichomonas vaginalis. Korean J. Parasitol. 2022, 60, 195–200. [Google Scholar] [CrossRef]
  21. Kaczmarek, A.; Sobociński, W.; Wesołowska, M.; Gołąb, E.; Kołodziej-Sobocińska, M.; Sałamatin, R. Blastocystis Occurrence and Subtype Diversity in Wild European Terrestrial Mammals—The Case of Białowieża Primeval Forest (NE Poland). Int. J. Parasitol. Parasites Wildl. 2021, 16, 120–125. [Google Scholar] [CrossRef] [PubMed]
  22. Kaczmarek, A.; Gołąb, E.; Sałamatin, R. Improved Blastocystis Spp. Detection Method Using Swabs with Amies Transport Medium and Charcoal. Ann. Agric. Environ. Med. 2022, 29, 303–305. [Google Scholar] [CrossRef] [PubMed]
  23. Clark, C.G.G. Extensive Genetic Diversity in Blastocystis hominis. Mol. Biochem. Parasitol. 1997, 87, 79–83. [Google Scholar] [CrossRef]
  24. Scicluna, S.M.; Tawari, B.; Clark, C.G. DNA Barcoding of Blastocystis. Protist 2006, 157, 77–85. [Google Scholar] [CrossRef]
  25. Poirier, P.; Wawrzyniak, I.; Albert, A.; El Alaoui, H.; Delbac, F.; Livrelli, V. Development and Evaluation of a Real-Time PCR Assay for Detection and Quantification of Blastocystis Parasites in Human Stool Samples: Prospective Study of Patients with Hematological Malignancies. J. Clin. Microbiol. 2011, 49, 975–983. [Google Scholar] [CrossRef] [PubMed]
  26. Sayers, E.W.; Beck, J.; Brister, J.R.; Bolton, E.E.; Canese, K.; Comeau, D.C.; Funk, K.; Ketter, A.; Kim, S.; Kimchi, A.; et al. Database Resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2020, 48, D9–D16. [Google Scholar] [CrossRef]
  27. Huelsenbeck, J.P.; Ronquist, F. Bayesian Analysis of Molecular Evolution Using MrBayes. In Statistical Methods in Molecular Evolution; Springer: New York, NY, USA, 2005; pp. 183–226. [Google Scholar]
  28. Ronquist, F.; Teslenko, M.; van der Mark, P.; Ayres, D.L.; Darling, A.; Höhna, S.; Larget, B.; Liu, L.; Suchard, M.A.; Huelsenbeck, J.P. MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice across a Large Model Space. Syst. Biol. 2012, 61, 539–542. [Google Scholar] [CrossRef]
  29. Miller, M.A.; Pfeiffer, W.; Schwartz, T. Creating the CIPRES Science Gateway for Inference of Large Phylogenetic Trees. In Proceedings of the 2010 Gateway Computing Environments Workshop, GCE 2010, New Orleans, LA, USA, 14 November 2010. [Google Scholar] [CrossRef]
  30. Mattiucci, S.; Crisafi, B.; Gabrielli, S.; Paoletti, M.; Cancrini, G. Molecular Epidemiology and Genetic Diversity of Blastocystis Infection in Humans in Italy. Epidemiol. Infect. 2016, 144, 635–646. [Google Scholar] [CrossRef]
  31. Rivera, W.L. Phylogenetic Analysis of Blastocystis Isolates from Animal and Human Hosts in the Philippines. Vet. Parasitol. 2008, 156, 178–182. [Google Scholar] [CrossRef]
  32. Alfellani, M.A.; Taner-Mulla, D.; Jacob, A.S.; Imeede, C.A.; Yoshikawa, H.; Stensvold, C.R.; Clark, C.G. Genetic Diversity of Blastocystis in Livestock and Zoo Animals. Protist 2013, 164, 497–509. [Google Scholar] [CrossRef]
  33. Stensvold, C.R.; Suresh, G.K.; Tan, K.S.W.; Thompson, R.C.A.; Traub, R.J.; Viscogliosi, E.; Yoshikawa, H.; Clark, C.G. Terminology for Blastocystis Subtypes—A Consensus. Trends Parasitol. 2007, 23, 93–96. [Google Scholar] [CrossRef] [PubMed]
  34. Engberts, M.K.; Goedbloed, A.F.; Van Haaften, M.; Boon, M.E.; Heintz, P.M. Microscopic Diagnosis of Vulvovaginal Candidiasis in Stained Vaginal Smears by Dutch General Practitioners. Acta Cytol. 2007, 51, 882–885. [Google Scholar] [CrossRef] [PubMed]
  35. Patino, W.D.; Cavuoti, D.; Banerjee, S.K.; Swartz, K.; Ashfaq, R.; Gokaslan, T. Cytologic Diagnosis of Blastocystis hominis in Peritoneal Fluid. Acta Cytol. 2008, 52, 718–720. [Google Scholar] [CrossRef] [PubMed]
  36. Crespillo-Andujar, C.; Díaz-Menéndez, M.; Mora-Rillo, M. Evidence for Previously Unidentified Sexual Transmission of Protozoan Parasites. Emerg. Infect. Dis. 2018, 24, 602–603. [Google Scholar] [CrossRef]
  37. Santín, M.; Gómez-Muñoz, M.T.; Solano-Aguilar, G.; Fayer, R. Development of a New PCR Protocol to Detect and Subtype Blastocystis spp. from Humans and Animals. Parasitol. Res. 2011, 109, 205–212. [Google Scholar] [CrossRef]
  38. Sepp, R.; Szabó, I.; Uda, H.; Sakamoto, H. Rapid Techniques for DNA Extraction from Routinely Processed Archival Tissue for Use in PCR. J. Clin. Pathol. 1994, 47, 318–323. [Google Scholar] [CrossRef]
  39. Feine, I.; Shpitzen, M.; Geller, B.; Salmon, E.; Peleg, T.; Roth, J.; Gafny, R. Acetone Facilitated DNA Sampling from Electrical Tapes Improves DNA Recovery and Enables Latent Fingerprints Development. Forensic Sci. Int. 2017, 276, 107–110. [Google Scholar] [CrossRef]
  40. Edgar, R.C. MUSCLE: Multiple Sequence Alignment with High Accuracy and High Throughput. Nucleic Acids Res. 2004, 32, 1792–1797. [Google Scholar] [CrossRef]
  41. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef]
  42. Reid, G.; Burton, J.; Devillard, E. The Rationale for Probiotics in Female Urogenital Healthcare. MedGenMed 2004, 6, 49. [Google Scholar]
  43. Reid, G.; Bruce, A.W.; Fraser, N.; Heinemann, C.; Owen, J.; Henning, B. Oral Probiotics Can Resolve Urogenital Infections. FEMS Immunol. Med. Microbiol. 2001, 30, 49–52. [Google Scholar] [CrossRef] [PubMed]
  44. Gholiof, M.; Adamson-De Luca, E.; Wessels, J.M. The Female Reproductive Tract Microbiotas, Inflammation, and Gynecological Conditions. Front. Reprod. Health 2022, 4, 963752. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Phylogenetic inference of the 18S rRNA gene partial sequence of Blastocystis STs. Bayesian posterior probabilities are shown adjacent to the branch nodes.
Figure 1. Phylogenetic inference of the 18S rRNA gene partial sequence of Blastocystis STs. Bayesian posterior probabilities are shown adjacent to the branch nodes.
Jcm 14 03928 g001
Table 1. List of primers and sizes of amplified products.
Table 1. List of primers and sizes of amplified products.
PrimersSequencesSize of ProductSources
RD55′-GGA AGC TTA TCT GGT TGA TCC TGC CAG TA-3′ca. 560 bp[23]
BHRDr5′-GAG CTT TTT AAC TGC AAC AAC G-3′[24]
Bl18SPPF15′-AGT AGT CAT ACG CTC GTC TCA AA-3′ca. 340 bp[25]
BL18SR2PP5′-TCT TCG TTA CCC GTT ACT GC-3′
bp—base pair; ca.—circa (approximately).
Table 2. GenBank reference sequences used in the construction of phylogenetic tree.
Table 2. GenBank reference sequences used in the construction of phylogenetic tree.
SubtypeNumber in the GenBank Database
ST1AB070989 (human), U51151 (human), AB107967 (monkey)
ST2AB070987 (human), AB070997 (monkey), AB107969 (monkey)
ST3AB070988 (human), AB091234 (human), AB107963 (pig)
ST4AB071000 (rat), AY135408 (rat), MT898453 (human), U51152 (guinea pig)
ST5AB070999 (pig), AB107964 (pig), AB070998 (pig)
ST6AB107972 (partridge), AB070995 (quail), AB070990 (human), MW538478 (chicken)
ST7AY135412 (duck), AB070991 (human), AF408427 (human), MW538476 (chicken)
ST8AB107970 (black-and-white ruffed lemur)
ST9AF408425 (human), AF408426 (human), KC138681 (human)
ST10KX352006 (water), KC148207 (dromedary), MT898456 (cattle), MT898457 (cattle), MZ265404 (goat), OM883870 (muskox), OM883871 (sheep), OR117623 (cattle), OR117633 (goat), OR117634 (goat), OR117647 (sheep)
ST11MT898454 (elephant), MT898455 (elephant)
ST12EU427515 (northern swamp wallaby)
ST13KC148209 (java mouse-deer)
ST14KC148205 (cattle), MT898458 (cattle), MT898459 (cattle)
ST15KC148210 (dromedary), KC148211 (gibbon), MK801387 (pig)
ST16EU427512 (red kangaroo), EU427514 (red kangaroo)
ST17KC148208 (common gundi)
ST21MW887929 (white-tailed deer)
ST23MW887931 (cattle), MZ265406 (goat), OR117664–OR117667 (goat)
ST24MW887928 (white-tailed deer)
ST25MW887933 (cattle)
ST26MW887932 (cattle)
ST27MW887934 (indian peafowl)
ST28MW887935 (indian peafowl)
ST29MW538473(chicken)
ST30MZ267674 (white-tailed deer)
ST31MZ267676 (white-tailed deer)
ST32MZ265403 (goat)
ST33ON932569 (horse)
ST34ON932571 (horse)
ST35OP720870 (human)
ST36OP720871 (bat)
ST37OP720872 (heteromyd)
ST38OP720869 (water vole)
ST39OP563846 (monkey)
ST41OQ703608 (human)
ST42OR117626–OR117632 (cattle), OR117653 (red-deer), OR117654–OR117657 (cattle)
ST43OR117658 (goat), OR117659 (goat), OR117660–OR117663 (sheep)
ST44MZ267675 (white-tailed-deer), MZ267679 (white-tailed-deer), OM883872 (sheep), OR117624 (cattle), OR117625 (cattle), OR117648–OR117652 (sheep)
Table 3. Blastocystis presence in swabs taken from the cervix and anus.
Table 3. Blastocystis presence in swabs taken from the cervix and anus.
PatientsGroup of Women with Erosion
CervixAnus
Patient 4+ (ST1)
Patient 6+ (ST1)
Patient 7+ (ST7)+ (ST3)
Patient 9+ (ST1)
Patient 17+ (ST6)
Patient 18+ (ST7)
Patient 19+ (ST1)
Patient 22+ (ST7)
Patient 30+ (ST7)
‘+’ indicates detection of Blastocystis; ‘–’ indicates no detection. The subtype of Blastocystis identified is shown in parentheses.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Suchońska, B.; Kaczmarek, A.; Wesołowska, M.; Młocicki, D.; Sałamatin, R. Molecular Identification of Blastocystis Subtypes in the Cervix: A Study on Polish Patients. J. Clin. Med. 2025, 14, 3928. https://doi.org/10.3390/jcm14113928

AMA Style

Suchońska B, Kaczmarek A, Wesołowska M, Młocicki D, Sałamatin R. Molecular Identification of Blastocystis Subtypes in the Cervix: A Study on Polish Patients. Journal of Clinical Medicine. 2025; 14(11):3928. https://doi.org/10.3390/jcm14113928

Chicago/Turabian Style

Suchońska, Barbara, Adam Kaczmarek, Maria Wesołowska, Daniel Młocicki, and Rusłan Sałamatin. 2025. "Molecular Identification of Blastocystis Subtypes in the Cervix: A Study on Polish Patients" Journal of Clinical Medicine 14, no. 11: 3928. https://doi.org/10.3390/jcm14113928

APA Style

Suchońska, B., Kaczmarek, A., Wesołowska, M., Młocicki, D., & Sałamatin, R. (2025). Molecular Identification of Blastocystis Subtypes in the Cervix: A Study on Polish Patients. Journal of Clinical Medicine, 14(11), 3928. https://doi.org/10.3390/jcm14113928

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop